Immediate Impact
3 from Science/Nature 65 standout
Citing Papers
Trial of Beremagene Geperpavec (B-VEC) for Dystrophic Epidermolysis Bullosa
2022 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Works of Ruth Gershoni being referenced
Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: An update
2005
Junctional epidermolysis bullosa in the Middle East: Clinical and genetic studies in a series of consanguineous families
2002
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Ruth Gershoni | 97 | 235 | 26 | 204 | 168 | 9 | 604 | |
| Jessica Fields | 24 | 122 | 18 | 218 | 107 | 33 | 733 | |
| Jan Pedersen | 105 | 159 | 74 | 79 | 95 | 26 | 588 | |
| James E. Coxworth | 38 | 122 | 2 | 150 | 20 | 13 | 556 | |
| Mahboob Sobhan | 26 | 88 | 293 | 44 | 136 | 10 | 713 | |
| Susanne F. Meisel | 73 | 219 | 15 | 27 | 75 | 27 | 540 | |
| R W Taylor | 67 | 168 | 85 | 25 | 49 | 33 | 734 | |
| Lakshmi Narayanan | 189 | 34 | 15 | 155 | 44 | 13 | 628 | |
| Vivienne Schnieden | 25 | 296 | 10 | 17 | 117 | 20 | 514 | |
| Jennifer L. Whitehead | 220 | 128 | 66 | 248 | 53 | 10 | 723 | |
| Victoria M. Basham | 88 | 166 | 1 | 43 | 33 | 25 | 687 |
All Works
Loading papers...